Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -229,918 | -119,632 | 681,313 | 779,525 | 875,668 |
| Depreciation Amortization | -197 | 3,077 | 10,870 | 7,799 | 5,115 |
| Accounts receivable | 5,914 | 319 | -25,505 | -16,179 | -19,557 |
| Accounts payable and accrued liabilities | 3,480 | 5,156 | 971 | 2,611 | 5,791 |
| Other Working Capital | 50,672 | 15,623 | -39,006 | 2,210 | -4,253 |
| Other Operating Activity | 35,232 | 14,562 | 89,571 | 59,798 | 44,412 |
| Operating Cash Flow | $-134,817 | $-80,895 | $718,214 | $835,764 | $907,176 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 634,145 | N/A | N/A | 467,658 | -845,108 |
| PPE Investments | -17,291 | -5,648 | -11,606 | -2,919 | -1,097 |
| Purchase Of Investment | -603,702 | -368,739 | -2,271,250 | -1,944,178 | N/A |
| Sale Of Investment | N/A | 362,249 | 902,920 | 11,963 | N/A |
| Investing Cash Flow | $13,152 | $-12,138 | $-1,379,936 | $-1,467,476 | $-846,205 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,200 | 4,894 | 851,966 | 849,298 | 845,439 |
| Financing Cash Flow | $12,200 | $4,894 | $851,966 | $849,298 | $845,439 |
| Exchange Rate Effect | -16 | -14 | -101 | -87 | -47 |
| Beginning Cash Position | 194,905 | 194,905 | 4,762 | 4,762 | 4,762 |
| End Cash Position | 85,424 | 106,752 | 194,905 | 222,261 | 911,125 |
| Net Cash Flow | $-109,481 | $-88,153 | $190,143 | $217,499 | $906,363 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,817 | -80,895 | 718,214 | 835,764 | 907,176 |
| Capital Expenditure | -17,291 | -5,648 | -14,239 | -5,552 | -3,730 |
| Free Cash Flow | -152,108 | -86,543 | 703,975 | 830,212 | 903,446 |